DMD Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on October 28, 2005; DOI: 10.1124/dmd.105.005652


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.005652v1
34/2/199    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuehl, G. E
Right arrow Articles by Lampe, J. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuehl, G. E
Right arrow Articles by Lampe, J. W


Received for publication May 26, 2005.
Revised October 26, 2005.
Accepted for publication October 26, 2005.

Glucuronidation of the aspirin metabolite salicylic acid by expressed UGTs and human liver microsomes

Gwendolyn E Kuehl 1, Jeannette Bigler 1, John D Potter 1, Johanna W Lampe 1*

1 Fred Hutchinson Cancer Research Center

* Address correspondence to: E-mail: jlampe{at}fhcrc.org

Abstract

Acetylsalicylic acid (aspirin) is a common nonsteroidal anti-inflammatory drug (NSAID) used for treatment of pain and arthritis. In the body, acetylsalicylic acid is rapidly deacetylated to form salicylic acid. Both compounds have been proposed as anti-inflammatory agents. Major metabolites of salicylic acid are its acyl and phenolic glucuronide conjugates. Formation of these conjugates, catalyzed by UDP-glucuronosyltransferases (UGTs), decreases the amount of pharmacologically active salicylic acid present. We aimed to identify the UGTs catalyzing the glucuronidation of salicylic acid using both heterologously expressed enzymes and pooled human liver microsomes (HLM) and to develop a liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) method to quantify glucuronidation activity of UGTs 1A1, 1A3, 1A4, 1A6, 1A7, 1A8, 1A9, 1A10, 2B4, 2B7, 2B15 and 2B17 SupersomesTM. All UGTs tested, except 1A4, 2B15 and 2B17, catalyzed salicylic acid phenolic and acyl glucuronidation. Ratios of salicylic acid phenolic to acyl glucuronide formation varied more than 12-fold from 0.5 for UGT1A6 to 6.1 for UGT1A1. These results suggest that all UGTs except 1A4, 2B15, and 2B17 might be involved in the glucuronidation of salicylic acid in vivo. From comparisons of apparent Km values determined in pooled HLM and in expressed UGTs, UGT2B7 was suggested as a likely catalyst of salicylic acid acyl glucuronidation while multiple UGTs were suggested as catalysts of phenolic glucuronidation. The results of this UGT screening may help target future evaluation of effects of UGT polymorphisms on response to aspirin in clinical and population-based studies.


Key words: glucuronidation, non-steroidal anti-inflammatory drugs, UDP glucuronyltransferases


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. T. Stern, M. N. Tallman, K. K. Miles, J. K. Ritter, and P. C. Smith
Androgen Regulation of Renal Uridine Diphosphoglucuronosyltransferase 1A1 in Rats
Drug Metab. Dispos., September 1, 2008; 36(9): 1737 - 1739.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. K. Chow, A. Castrillo, A. Shahangian, L. Pei, R. M. O'Connell, R. L. Modlin, P. Tontonoz, and G. Cheng
A role for IRF3-dependent RXR{alpha} repression in hepatotoxicity associated with viral infections
J. Exp. Med., November 27, 2006; 203(12): 2589 - 2602.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.